Back to search
FDAFDA · Food and drugs·Recall number D-0544-2018

Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478

Published March 7, 2018 · Recall initiated: February 9, 2018

Summary

FDA records drug Class II recall D-0544-2018, published March 7, 2018 and initiated February 9, 2018. Recalling firm: Apace KY LLC; Status: Terminated; Reported quantity: 630 cartons; Lot: Lot: 19900, exp 05/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.

What to do

Voluntary: Firm initiated · Letter

Get an email if ACYCLOVIR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ACYCLOVIR
Manufacturer
Apace KY LLC
Distributor
Nationwide
Lot
Lot: 19900, exp 05/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478 recalled?

Yes. FDA published recall D-0544-2018 on March 7, 2018. Reported hazard: Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ACYCLOVIR.